Skip to main content
Top
Published in: Health and Technology 4/2019

03-01-2019 | Original Paper

Comparison of PET imaging with a 68Ga-labelled PSMA ligand versus 18F-choline PET/CT for the diagnosis of Prostate Cancer & Radioprotection for involved personnel

Authors: Zeinab Khansa, Mohamad B. Haidar, Nemer Neaimeh, Mahmoud Korek

Published in: Health and Technology | Issue 4/2019

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

To compare the radiation dose delivered by Positron Emission Tomography (PET) due to Gallium-68 (68Ga) and Fluorine-18(18F) performed for patients with prostate cancer. The greatest importance is to understand how the extremely strong sources in use can be managed effectively and doses to persons and unwanted doses to patients can be minimized. Thus, Radiation safety measurements are necessary to achieve the lowest exposure with reasonable cost and effort. We prospectively analyzed studies from 70 patients who underwent PET-CT using 68Ga or 18F for diagnosis of prostate cancer between January 2017 and December 2017 at the American University of Beirut Medical Center. The dose rates were measured during the uptake period at patient body surface (abdomen) and at 1 m distance; these two points were measured after one hour of radionuclide uptake with background of 0.018 μSv. Then, the equivalent dose is calculated. Patients were selected consecutively until 70 cases were selected for each type of radionuclide. Data on 140 patients are presented. The maximum dose given to 68Ga PSMA (prostate-specific membrane antigen) patients was 5.80 mCi while doses to 18F-Choline patients reached 8.87 mCi. Cronbach’s Alpha values for the correlation between the masses and the dose rates was 0.530.Thus there is a small positive relationship between the body masses and the dose rates. This relationship is not statistically significant. Furthermore, the equivalent dose for both radionuclides was constant whatever the mass of the patient is. There is no effect of the body mass with respect to the dose rate, and equivalent dose due to both radionuclides 68Ga and 18F, which coincides with the principles of radiation protection. This leads to the suggestion that PET/CT equivalent doses with 68Ga-labelled PSMA ligand or 18F-Choline are similar and safe in the diagnosis of prostate cancer. However, 68Ga PSMA coincides more with radiation protection principles since the maximum equivalent dose due to 68Ga after 1 h at 1 m was 17.71 μSv while the maximum equivalent dose due to 18F after 1 h at 1 m was 39.51 μSv.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literature
1.
go back to reference International Commission on Radiological Protection. Radiological protection in medicine. ICRP Publication 105. Ann ICRP. 2007;37:1–63. International Commission on Radiological Protection. Radiological protection in medicine. ICRP Publication 105. Ann ICRP. 2007;37:1–63.
2.
go back to reference Menzel F et al. Using of BEPU methodology in a final safety analysis report. 2015. Menzel F et al. Using of BEPU methodology in a final safety analysis report. 2015.
4.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: CA Cancer J Clin. 2011;61:69–90. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: CA Cancer J Clin. 2011;61:69–90.
5.
go back to reference Shamseddine A, Saleh A, Charafeddine M, Seoud M, Mukherji D, Temraz S, et al. Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018. Popul Health Metr. 2014;12:4.CrossRef Shamseddine A, Saleh A, Charafeddine M, Seoud M, Mukherji D, Temraz S, et al. Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018. Popul Health Metr. 2014;12:4.CrossRef
6.
go back to reference Grant FD et al. Skeletal PET with^ 1^ 8F-Fluoride: applying new technology to an old tracer. J Nuclear Med. 2008: 68. Grant FD et al. Skeletal PET with^ 1^ 8F-Fluoride: applying new technology to an old tracer. J Nuclear Med. 2008: 68.
7.
go back to reference Pagani M, Stone-Elander S, Larsson SA. Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applications. Eur J Nucl Med. 1997:1301–27. Pagani M, Stone-Elander S, Larsson SA. Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applications. Eur J Nucl Med. 1997:1301–27.
9.
go back to reference Dwivedi DK et al. Radiation exposure to nuclear medicine personnel handling positron emitters from Ge-68/Ga-68 generator. Indian J Nucl Med: IJNM: Off J Soc Nucl Med, India. 2011: 86. Dwivedi DK et al. Radiation exposure to nuclear medicine personnel handling positron emitters from Ge-68/Ga-68 generator. Indian J Nucl Med: IJNM: Off J Soc Nucl Med, India. 2011: 86.
10.
go back to reference International Commission on Radiological Protection. Committee IV on Protection Against Electromagnetic Radiation Above 3 MeV and Electrons, Neutrons, and Protons. Radiation protection; recommendations of the International Commission on Radiological Protection: Report of Committee IV (1953–1959) on Protection against Electromagnetic Radiation above 3 MeV and Electrons, Neutrons and Protons. Adopted 1962, with revisions adopted in 1963. Vol. 4. Published for the International Commission on Radiological Protection [by] MacMillan, 1964. International Commission on Radiological Protection. Committee IV on Protection Against Electromagnetic Radiation Above 3 MeV and Electrons, Neutrons, and Protons. Radiation protection; recommendations of the International Commission on Radiological Protection: Report of Committee IV (1953–1959) on Protection against Electromagnetic Radiation above 3 MeV and Electrons, Neutrons and Protons. Adopted 1962, with revisions adopted in 1963. Vol. 4. Published for the International Commission on Radiological Protection [by] MacMillan, 1964.
11.
go back to reference Kendall GM, Smith TJ. Doses to organs and tissues from radon and its decay products. J Radiol Prot. 2002:389. Kendall GM, Smith TJ. Doses to organs and tissues from radon and its decay products. J Radiol Prot. 2002:389.
12.
go back to reference Valentin J. Basic anatomical and physiological data for use in radiological protection: reference values: ICRP publication 89.Ann ICRP. 2002: 1–277. Valentin J. Basic anatomical and physiological data for use in radiological protection: reference values: ICRP publication 89.Ann ICRP. 2002: 1–277.
13.
go back to reference Martin CJ. Effective dose: how should it be applied to medical exposures?. The British J Radiol. 2007: 639–647. Martin CJ. Effective dose: how should it be applied to medical exposures?. The British J Radiol. 2007: 639–647.
14.
go back to reference Salame-Alfie A. Assessing dose of the representative person for the purpose of radiation protection of the public and the optimization of radiological protection: broadening the process. Health Phys. 2008: 373–374. Salame-Alfie A. Assessing dose of the representative person for the purpose of radiation protection of the public and the optimization of radiological protection: broadening the process. Health Phys. 2008: 373–374.
15.
go back to reference Ferrari A, Pelliccioni M, Pillon M. Fluence to effective dose and effective dose equivalent conversion coefficients for photons from 50 keV to 10 GeV. Radiat Prot Dosim. 1996: 245–251. Ferrari A, Pelliccioni M, Pillon M. Fluence to effective dose and effective dose equivalent conversion coefficients for photons from 50 keV to 10 GeV. Radiat Prot Dosim. 1996: 245–251.
16.
go back to reference Pant GS, Senthamizhchelvan S. Radiation exposure to staff in a PET/CT facility. Indian J Nucl Med. 2006: 100–3. Pant GS, Senthamizhchelvan S. Radiation exposure to staff in a PET/CT facility. Indian J Nucl Med. 2006: 100–3.
17.
go back to reference Demir M et al. Radiation protection for accompanying person and radiation workers in PET/CT. Radiation Protect Dosimet. 2010: 528–532. Demir M et al. Radiation protection for accompanying person and radiation workers in PET/CT. Radiation Protect Dosimet. 2010: 528–532.
18.
go back to reference Benatar NA, Cronin BF, O'doherty M. Radiation doses received by staff and carers/escorts following contact with IsF-FDG PET patients. 1999: 462. Benatar NA, Cronin BF, O'doherty M. Radiation doses received by staff and carers/escorts following contact with IsF-FDG PET patients. 1999: 462.
Metadata
Title
Comparison of PET imaging with a 68Ga-labelled PSMA ligand versus 18F-choline PET/CT for the diagnosis of Prostate Cancer & Radioprotection for involved personnel
Authors
Zeinab Khansa
Mohamad B. Haidar
Nemer Neaimeh
Mahmoud Korek
Publication date
03-01-2019
Publisher
Springer Berlin Heidelberg
Published in
Health and Technology / Issue 4/2019
Print ISSN: 2190-7188
Electronic ISSN: 2190-7196
DOI
https://doi.org/10.1007/s12553-018-00281-5

Other articles of this Issue 4/2019

Health and Technology 4/2019 Go to the issue

Premium Partner